News
1d
MedPage Today on MSNPridopidine Shows Promise in Subgroup of Huntington's PatientsTreatment with investigational pridopidine seemed to offer benefits for certain patients with Huntington's disease, according ...
2d
MedPage Today on MSNAnti-CGRP Drug Reduces Episodic Migraine in KidsFremanezumab (Ajovy) cut monthly migraine days in children and adolescents with episodic migraine, according to the SPACE ...
An experimental drug can help patients with advanced multiple sclerosis delay the progressive disability that comes with ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
Dozens of trials testing GLP-1 drugs like semaglutide, the medicine in Ozempic and Wegovy, against a placebo suggest that ...
Study participants see significant relief from PMS symptoms even though they know they are taking a placebo. Here’s how ‘open-label’ placebos work.
Popular medications for obesity and diabetes have been linked to an increased risk of hair loss, particularly for women. Researchers and doctors weigh in.
As therapy becomes more common, concerns grow over medication dependency, the effectiveness of young therapists, and whether modern mental health treatment is addressing deeper societal issues.
In a small Phase II trial, people with cocaine use disorder who took mavoglurant used the drug less often over a three month ...
The FDA approved several therapies in oncology in the month of March 2025. These drugs included treatments for ...
Contrave and Wegovy are both weight loss medications. Learn about their effectiveness, side effects, costs, and which ...
AstraZeneca’s AZD0780 is an investigational oral medication that was developed to lower low-density lipoprotein cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results